FDA Inspection 817330 — Strides Pharma, Inc.

Strides Pharma, Inc. — FEI 2434223

The FDA completed an inspection of Strides Pharma, Inc. on Feb 19, 2013 in Chestnut Ridge, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Feb 19, 2013
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Chestnut Ridge, NY (United States)

Citations

IDCFRDescription
135821 CFR 211.100(b)SOPs not followed / documented
358521 CFR 211.110(a)Control procedures to monitor and validate performance
438921 CFR 211.198(a)Procedures to be written and followed

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.